Cisatracurium Besylate Injection
Product Images NDC 70069-161

This text is not readable.*

Cisatracurium Besylate Injection is a prescription medication that comes in 10mL multiple-dose vials with a concentration of 20 mg/10mL. It contains benzyl alcohol as a preservative to keep the drug sterile. It is a paralyzing agent, which means it has the potential to cause respiratory arrest, and facilities must have the resources available for artificial respiration. The drug should be stored at 2° to 8°C and protected from light to maintain proper efficacy. The vial should be discarded according to the instructions after use. It is manufactured by Somerset Therapeutics in India.*

Cisatracurium Besylate is an injection used for intravenous purposes only. The solution comes in a 110 mL multiple-dose vial with a warm warning as a paralyzing agent and may cause respiratory arrest. The usual dosage is mentioned, and storage conditions are specified. The solution should not be frozen or exposed to light. It contains 0.9% benzyl alcohol as a preservative. The manufacturer is Somerset Therapeutics LLC, and the customer service number is available for contact. The given text is a medical description of the product.*

Cisatracurium Besylate Injection is a nonpyrogeric solution for intravenous injection. It is a paralyzing agent that may cause respiratory arrest, hence requires immediate availability of artificial respiration facilities. Each mL contains clsatracurlum 2 mg equivalent and 0.9% benzyl alcohol as a preservative. It is recommended to store it at -8°C and avoid freezing and light. Once removed from refrigeration, it should be used within 21 days, even if not re-refrigerated. The usual dosage is mentioned in the package insert for full prescribing information. The product is manufactured for Somerset Therapeutics in India and is sold as 10x 10 mL multiple-dose vials. The text also contains warnings and customer care information.*